Why Do We Switch Treatments for Multiple Sclerosis?

Published: Jul 31, 2024

Multiple sclerosis (MS) is a tricky condition to manage, often requiring changes in treatment. Let's explore why switching treatments might be necessary and what it involves.
Contents

Understanding the Need for Change

Sometimes, MS treatments, known as disease-modifying therapies (DMTs), don't work as well as they should. If a person experiences serious relapses or new lesions on MRI scans after being on a treatment for a while, it might be time to consider other options. The American Academy of Neurology suggests switching if there's no improvement over a year, especially with multiple relapses or worsening disability.

When to Reconsider Diagnosis

Occasionally, what looks like MS progression might actually be something else. If symptoms worsen despite high-efficacy DMTs, doctors may reassess the diagnosis. Conditions like neuromyelitis optica can mimic MS but require different treatments. Recognizing 'pseudorelapses,' where symptoms temporarily worsen due to factors like fever, is also vital.
Multiple sclerosis (MS) is a chronic condition affecting the central nervous system, often requiring treatment changes due to relapses or new lesions. Accurate diagnosis is crucial for effective management.

Monitoring MS Activity

Doctors use various scoring systems to track MS activity and treatment effectiveness. The Rio and modified Rio scores help predict outcomes based on relapses and MRI changes. NEDA, or No Evidence of Disease Activity, is another benchmark aiming for no relapses or new brain lesions.

Frequently Asked Questions

Switching is considered when current treatments aren't effective.

It's a temporary worsening of symptoms not due to a true relapse.

No Evidence of Disease Activity.

The Bottom Line

Switching MS treatments is a complex decision requiring careful evaluation.
Next steps: Discuss your MS treatment options with Doctronic to find what's best for you.

Related Articles

References

  1. Sormani MP, Gasperini C, Romeo M, et al. Assessing response to interferon-β in a multicenter dataset of patients with MS. Neurology 2016; 87:134.
  2. Sormani M, Signori A, Stromillo M, De Stefano N. Refining response to treatment as defined by the Modified Rio Score. Mult Scler 2013; 19:1246.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely